Posted in | News

Inovatec System Concludes Negotiations with First Licensee Partner in Brazil

Inovatec is pleased to announce the successful conclusion of negotiations with its first Licensee Partner in Brazil.

As a result, factory setup activities are on track to open the company's first manufacturing facility to fulfill the demand for affordable housing of the Brazilian Government's "Minha Casa Minha Vida" program. The state-of-art facility is scheduled to commence operation in Q1 2014 and it will be the company's first fully automated continuous production line in the world.

Inovatec System strives to be the premier global provider of Reinforced Fiber Composite solutions for the residential and commercial construction industry. Our global growth strategy leads us to identify local partners in foreign countries to form Joint Ventures or License the technology setup for local manufacturing facilities.

Inovatec manufactures and delivers construction solutions based on its patented, state-of-the-art FCSE (Fiber Composite Structural Elements) and bonding agents that are produced using proprietary, synthetic, composite materials and industrial processes similar to those widely accepted by the wind, marine and aerospace industries. This cutting-edge technology addresses the design, engineering, manufacturing, and installation of every type of residential and commercial building. Inovatec building solutions bridge the gap between energy efficiency, high quality and affordability while delivering finished product in 1/5 of the time when compared to traditional construction. All pre-fabricated elements are manufactured in state-of-the-art facilities and shipped to the jobsite ready for assembly.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.